Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
NCT01190072
·
clinicaltrials.gov ↗
TERMINATED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Sponsor
AstraZeneca